Company News

  • Snibe become the 1st in China who received FDA Cleared on CLIA product

    14th July 2017- Snibe Co., Ltd. receives the FDA clearance on the commercialization of TSH on MaglumiTM 2000 fully-automatic chemiluminescence immunoassay system. (US FDA 510 (k), K NO. : K162698) .It is the 1st company in China who received FDA cleared on CLIA product.
    Issue date:2017-10-27
  • Snibe Shows Great Charms at EuroMedlab 2019 in Barcelona

    EuroMedLab Barcelona 2019, the largest exhibition in the field of Clinical Chemistry and Laboratory Medicine in Europe, which attracted more than 5000 participants, was held in Barcelona International Convention Centre (CCIB) from May 19th to 23rd, 2019.
    Issue date:2019-05-27
  • Snibe participated in the Medlab Asia Pacific 2019 as a Diamond Sponsor, Singapore

    MEDLAB Asia Pacific 2019 is held in Singapore from March 26th to 28th. This is a trade show where several main solutions and products about Medical, Oncology, Healthcare Industry, Cancer, Laboratory, Healthcare System, Clinical Chemistry, Molecular Diagnostics and Laboratory Medicine tend to put on.
    Issue date:2019-03-28

New Product

More >>

About Us

To Be Global IVD Pioneer

Focus On Chemiluminescence Immunoassay For 24years

144Countries

11000Units

More
英雄吕布电子游戏 江西多乐彩最大遗漏 装冠通棋牌下载 重庆幸运农场果蔬开奖 适合平民赚钱的网游 pk10冠亚11不算和 中国福利彩票双色球走势图 提现棋牌信誉排行榜 彩票控北京赛车开奖 舟山体彩飞鱼投注技巧 上海股票推荐 北京pk10下载软件 体彩专家杀号技巧 模拟人生3宠物怎么赚钱 河北11选5省保定市计划生育 360双色球综合分布图 网上配货赚钱秘诀